IV. Symptomkontrolle (II)

Steffen Simon

doi:10.1055/s-0031-1300578

Arzneimittelforschung, Table of Contents

Arzneimittelforschung 2011; 61(11): 659-660
DOI: 10.1055/s-0031-1300578

PMS-Symposium Innovative Therapies in Palliative Care

Editio Cantor Verlag Aulendorf (Germany)

IV. Symptomkontrolle (II)

State of the art in der Therapie der Atemnot

Authors

Steffen Simon

¹Zentrum für Palliativmedizin und Klinisches Studienzentrum Palliativmedizin, Uniklinik Köln

Abstract

Full Text

References

Literatur
1 Altfelder N, Nauck F, Alt-Epping B, Bausewein C, Simon ST. Characteristics of patients with breathlessness: a German national survey on palliative care in-patient units. Palliat Med. 2010; 24: S37
2 Bausewein C, Booth S, Gysels M, Kuehnbach R, Haberland B, Higginson IJ. Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study. Palliat Med. 2010; 24 (8) 777-86
3 American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999; 159 (1) 321-40
4 von LA, Vovk A, Bradley MM, Keil A, Lang PJ, Davenport PW. The impact of emotion on respiratory-related evoked potentials. Psychophysiology. 2010; 47 (3) 579-86
5 Gysels M, Bausewein C, Higginson IJ. Experiences of breathlessness: a systematic review of the qualitative literature. Palliat Support Care. 2007; 5 (3) 281-302
6 Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E. Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med. 2009; (l) 29-36
7 Bausewein C, Booth S, Gysels M, Higginson IJ. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008;
8 Booth S, Moffat C, Farquhar M, Higginson IJ, Burkin J. Developing a breathlessness intervention service for patients with palliative and supportive care needs, irrespective of diagnosis. J Palliat Care. 2011; 27 (l) 28-36
9 Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev 2001;
10 Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. Br Med J. 2003; 327 (7414) 523-8
11 Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010;
12 Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010; 376 (9743) 784-93
13 Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database Syst Rev 2008;
14 Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;